Trials / Sponsors / Inventprise Inc.
Inventprise Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Shigella, Diarrhea | Phase 1 | 2025-10-09 |
| Active Not Recruiting | Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Va Pneumococcal Disease, Invasive | Phase 2 | 2025-01-27 |
| Active Not Recruiting | Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, A Group B Streptococcal Infections | Phase 1 / Phase 2 | 2024-11-12 |
| Completed | Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine Pneumococcal Vaccines | Phase 2 | 2023-10-25 |
| Completed | Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine Pneumococcal Vaccines | Phase 1 | 2022-09-28 |